ALICETM CPB Device

A cardiopulmonary bypass (CPB) or heart-lung bypass device

Designed to oxygenate and circulate blood for up to 6 hours during cardiac surgery


The ALICE™ device is expected to be the first system designed for integration with the company’s non-invasive HYLA™ blood sensor technology, a device that performs continuous blood measurements in real time, potentially minimizing the need to collect blood samples from patients and assisting physicians in monitoring an individual’s clinical condition.

The ALICE™ device includes several Inspira Technologies developed features and capabilities, including a large touchscreen and novel colorful graphical representation that increases the visibility, scope and functionality of data displayed to the medical staff.
With its small footprint and lightweight characteristics, the ALICE™ device is being designed with a rapid style aerospace-grade aluminum structure to be both lightweight and highly durable, and will be equipped with long battery life, a contributing factor to making the device suitable for patient mobility within hospitals and for transportation of patients in ambulances.

The ALICE™ device is expected to be submitted to the FDA for approval during the first half of 2023.

Get in Touch!

    Ha-Tidhar St 2, Ra'anana, Israel

    I consent to receive emails from Inspira Technologies Oxy B.H.N LTD. To request removal from the mailing list at any time, please send an email to info@inspirao2.com. You can find out about your rights and privacy choices, and how we use your information in our Privacy Policy.

    Welcome to Inspira Technologies

    Please choose your location: